BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16007396)

  • 1. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.
    Kitase A; Hino K; Furutani T; Okuda M; Gondo T; Hidaka I; Hara Y; Yamaguchi Y; Okita K
    J Gastroenterol; 2005 Jun; 40(6):617-24. PubMed ID: 16007396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of malondialdehyde (MDA), 4-hydroxy-2-hexenal (HHE) and 4-hydroxy-2-nonenal (HNE) in fish and fish oil during dynamic gastrointestinal in vitro digestion.
    Larsson K; Harrysson H; Havenaar R; Alminger M; Undeland I
    Food Funct; 2016 Feb; 7(2):1176-87. PubMed ID: 26824872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress?
    Koike K
    J Gastroenterol; 2005 Jun; 40(6):664-5. PubMed ID: 16007406
    [No Abstract]   [Full Text] [Related]  

  • 4. Two Toxic Lipid Aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), Accumulate in Patients with Chronic Kidney Disease.
    Soulage CO; Pelletier CC; Florens N; Lemoine S; Dubourg L; Juillard L; Guebre-Egziabher F
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32899405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
    Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis.
    Arendt BM; Mohammed SS; Aghdassi E; Prayitno NR; Ma DW; Nguyen A; Guindi M; Sherman M; Heathcote EJ; Allard JP
    J Nutr; 2009 Apr; 139(4):691-5. PubMed ID: 19211827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE..
    Long EK; Picklo MJ
    Free Radic Biol Med; 2010 Jul; 49(1):1-8. PubMed ID: 20353821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization.
    Hartley DP; Kolaja KL; Reichard J; Petersen DR
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):23-33. PubMed ID: 10558920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
    Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
    J Clin Pathol; 1997 May; 50(5):401-6. PubMed ID: 9215123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells.
    Ishikado A; Nishio Y; Morino K; Ugi S; Kondo H; Makino T; Kashiwagi A; Maegawa H
    Biochem Biophys Res Commun; 2010 Nov; 402(1):99-104. PubMed ID: 20920477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steatosis in chronic hepatitis C: prevalence and predictive factors].
    Ouakaa-Kchaou A; Gargouri D; Kochlef A; Debbiche A; Elloumi H; Ghouma M; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2011 Nov; 89(11):830-6. PubMed ID: 22179918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation.
    Chung FL; Pan J; Choudhury S; Roy R; Hu W; Tang MS
    Mutat Res; 2003 Oct; 531(1-2):25-36. PubMed ID: 14637245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation.
    Long EK; Murphy TC; Leiphon LJ; Watt J; Morrow JD; Milne GL; Howard JR; Picklo MJ
    J Neurochem; 2008 May; 105(3):714-24. PubMed ID: 18194211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner.
    Long EK; Olson DM; Bernlohr DA
    Free Radic Biol Med; 2013 Oct; 63():390-8. PubMed ID: 23726997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal.
    Pillon NJ; Vella RE; Souleere L; Becchi M; Lagarde M; Soulage CO
    Chem Res Toxicol; 2011 May; 24(5):752-62. PubMed ID: 21462967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
    Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals.
    Bacot S; Bernoud-Hubac N; Chantegrel B; Deshayes C; Doutheau A; Ponsin G; Lagarde M; Guichardant M
    J Lipid Res; 2007 Apr; 48(4):816-25. PubMed ID: 17220481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.